Cite
Sodium Salicylate Inhibits Urokinase Activity in MDA MB-231 Breast Cancer Cells.
MLA
Madunić, Josip, et al. “Sodium Salicylate Inhibits Urokinase Activity in MDA MB-231 Breast Cancer Cells.” Clinical Breast Cancer, vol. 17, no. 8, Dec. 2017, pp. 629–37. EBSCOhost, https://doi.org/10.1016/j.clbc.2017.03.015.
APA
Madunić, J., Horvat, L., Majstorović, I., Jodłowska, I., Antica, M., & Matulić, M. (2017). Sodium Salicylate Inhibits Urokinase Activity in MDA MB-231 Breast Cancer Cells. Clinical Breast Cancer, 17(8), 629–637. https://doi.org/10.1016/j.clbc.2017.03.015
Chicago
Madunić, Josip, Luka Horvat, Ivana Majstorović, Iga Jodłowska, Mariastefania Antica, and Maja Matulić. 2017. “Sodium Salicylate Inhibits Urokinase Activity in MDA MB-231 Breast Cancer Cells.” Clinical Breast Cancer 17 (8): 629–37. doi:10.1016/j.clbc.2017.03.015.